These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 24321497)

  • 1. The oncogenic properties of EWS/WT1 of desmoplastic small round cell tumors are unmasked by loss of p53 in murine embryonic fibroblasts.
    Bandopadhayay P; Jabbour AM; Riffkin C; Salmanidis M; Gordon L; Popovski D; Rigby L; Ashley DM; Watkins DN; Thomas DM; Algar E; Ekert PG
    BMC Cancer; 2013 Dec; 13():585. PubMed ID: 24321497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of action of trabectedin in desmoplastic small round cell tumor cells.
    Uboldi S; Craparotta I; Colella G; Ronchetti E; Beltrame L; Vicario S; Marchini S; Panini N; Dagrada G; Bozzi F; Pilotti S; Galmarini CM; D'Incalci M; Gatta R
    BMC Cancer; 2017 Feb; 17(1):107. PubMed ID: 28166781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphoproteomic profiling of the mammalian target of rapamycin (mTOR) signaling pathway in desmoplastic small round cell tumor (EWS/WT1), Ewing's sarcoma (EWS/FLI1) and Wilms' tumor(WT1).
    Subbiah V; Brown RE; Jiang Y; Buryanek J; Hayes-Jordan A; Kurzrock R; Anderson PM
    PLoS One; 2013; 8(7):e68985. PubMed ID: 23922674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EWS-WT1 fusion isoforms establish oncogenic programs and therapeutic vulnerabilities in desmoplastic small round cell tumors.
    Boulay G; Broye LC; Dong R; Iyer S; Sanalkumar R; Xing YH; Buisson R; Rengarajan S; Naigles B; Duc B; Volorio A; Awad ME; Renella R; Chebib I; Nielsen GP; Choy E; Cote GM; Zou L; Letovanec I; Stamenkovic I; Rivera MN; Riggi N
    Nat Commun; 2024 Aug; 15(1):7460. PubMed ID: 39198430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine transporter ENT4 is a direct target of EWS/WT1 translocation product and is highly expressed in desmoplastic small round cell tumor.
    Li H; Smolen GA; Beers LF; Xia L; Gerald W; Wang J; Haber DA; Lee SB
    PLoS One; 2008 Jun; 3(6):e2353. PubMed ID: 18523561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The desmoplastic small round cell tumor t(11;22) translocation produces EWS/WT1 isoforms with differing oncogenic properties.
    Kim J; Lee K; Pelletier J
    Oncogene; 1998 Apr; 16(15):1973-9. PubMed ID: 9591781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular heterogeneity and function of EWS-WT1 fusion transcripts in desmoplastic small round cell tumors.
    Liu J; Nau MM; Yeh JC; Allegra CJ; Chu E; Wright JJ
    Clin Cancer Res; 2000 Sep; 6(9):3522-9. PubMed ID: 10999739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor.
    Slotkin EK; Bowman AS; Levine MF; Dela Cruz F; Coutinho DF; Sanchez GI; Rosales N; Modak S; Tap WD; Gounder MM; Thornton KA; Bouvier N; You D; Gundem G; Gerstle JT; Heaton TE; LaQuaglia MP; Wexler LH; Meyers PA; Kung AL; Papaemmanuil E; Zehir A; Ladanyi M; Shukla N
    Mol Cancer Res; 2021 Jul; 19(7):1146-1155. PubMed ID: 33753552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A tetraspanin-family protein, T-cell acute lymphoblastic leukemia-associated antigen 1, is induced by the Ewing's sarcoma-Wilms' tumor 1 fusion protein of desmoplastic small round-cell tumor.
    Ito E; Honma R; Imai J; Azuma S; Kanno T; Mori S; Yoshie O; Nishio J; Iwasaki H; Yoshida K; Gohda J; Inoue J; Watanabe S; Semba K
    Am J Pathol; 2003 Dec; 163(6):2165-72. PubMed ID: 14633590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Transcriptomic Analysis of EWSR1::WT1 Targets Identifies CDK4/6 Inhibitors as an Effective Therapy for Desmoplastic Small Round Cell Tumors.
    Magrath JW; Sampath SS; Flinchum DA; Hartono AB; Goldberg IN; Boehling JR; Savkovic SD; Lee SB
    Cancer Res; 2024 May; 84(9):1426-1442. PubMed ID: 38588409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lurbinectedin Inhibits the EWS-WT1 Transcription Factor in Desmoplastic Small Round Cell Tumor.
    Gedminas JM; Kaufman R; Boguslawski EA; Gross AC; Adams M; Beddows I; Kitchen-Goosen SM; Roberts RD; Grohar PJ
    Mol Cancer Ther; 2022 Aug; 21(8):1296-1305. PubMed ID: 35657345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EWSR1::WT1 Fusions in Neoplasms Other Than Conventional Desmoplastic Small Round Cell Tumor: Three Tumors Occurring Outside the Female Genital Tract.
    Warmke LM; Perret R; Ledoux P; Michot A; Italiano A; Zou YS; Matoso A; Argani P; Ulbright TM; Baumhoer D; Ameline B; Gross JM
    Mod Pathol; 2024 Mar; 37(3):100418. PubMed ID: 38158126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EWS-WT1 oncoprotein activates neuronal reprogramming factor ASCL1 and promotes neural differentiation.
    Kang HJ; Park JH; Chen W; Kang SI; Moroz K; Ladanyi M; Lee SB
    Cancer Res; 2014 Aug; 74(16):4526-35. PubMed ID: 24934812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumour.
    Lee SB; Kolquist KA; Nichols K; Englert C; Maheswaran S; Ladanyi M; Gerald WL; Haber DA
    Nat Genet; 1997 Nov; 17(3):309-13. PubMed ID: 9354795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel EWS-WT1 gene fusion product in desmoplastic small round cell tumor is a potent transactivator of the insulin-like growth factor-I receptor (IGF-IR) gene.
    Werner H; Idelman G; Rubinstein M; Pattee P; Nagalla SR; Roberts CT
    Cancer Lett; 2007 Mar; 247(1):84-90. PubMed ID: 16730884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Potential of NTRK3 Inhibition in Desmoplastic Small Round Cell Tumor.
    Ogura K; Somwar R; Hmeljak J; Magnan H; Benayed R; Momeni Boroujeni A; Bowman AS; Mattar MS; Khodos I; de Stanchina E; Jungbluth A; Asher M; Odintsov I; Hartono AB; LaQuaglia MP; Slotkin E; Pratilas CA; Lee SB; Spraggon L; Ladanyi M
    Clin Cancer Res; 2021 Feb; 27(4):1184-1194. PubMed ID: 33229458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptome analysis of desmoplastic small round cell tumors identifies actionable therapeutic targets: a report from the Children's Oncology Group.
    Hingorani P; Dinu V; Zhang X; Lei H; Shern JF; Park J; Steel J; Rauf F; Parham D; Gastier-Foster J; Hall D; Hawkins DS; Skapek SX; Labaer J; McEachron TA
    Sci Rep; 2020 Jul; 10(1):12318. PubMed ID: 32703985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The MDM2-a splice variant of MDM2 alters transformation in vitro and the tumor spectrum in both Arf- and p53-null models of tumorigenesis.
    Volk EL; Fan L; Schuster K; Rehg JE; Harris LC
    Mol Cancer Res; 2009 Jun; 7(6):863-9. PubMed ID: 19491200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A genomic case study of desmoplastic small round cell tumor: comprehensive analysis reveals insights into potential therapeutic targets and development of a monitoring tool for a rare and aggressive disease.
    Ferreira EN; Barros BD; de Souza JE; Almeida RV; Torrezan GT; Garcia S; Krepischi AC; Mello CA; Cunha IW; Pinto CA; Soares FA; Dias-Neto E; Lopes A; de Souza SJ; Carraro DM
    Hum Genomics; 2016 Nov; 10(1):36. PubMed ID: 27863505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, pathologic, and molecular spectrum of tumors associated with t(11;22)(p13;q12): desmoplastic small round-cell tumor and its variants.
    Gerald WL; Ladanyi M; de Alava E; Cuatrecasas M; Kushner BH; LaQuaglia MP; Rosai J
    J Clin Oncol; 1998 Sep; 16(9):3028-36. PubMed ID: 9738572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.